NextPlat (NXPL) Assets Average (2011 - 2026)
NextPlat's (NXPL) quarterly Assets Average came in at $27.8 million in Q2 2026, down 16.07% year-over-year from $33.1 million in Q2 2025, and up 2.22% quarter-over-quarter from $27.2 million in Q1 2026.
Analysis
NextPlat (NXPL) Assets Average (2011 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Assets Average for 14 consecutive years, with $27.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average fell 16.07% year-over-year to $27.8 million in Q2 2026; TTM through Jun 2026 was $27.8 million, a 16.07% decrease from a year earlier, with the FY2025 full-year figure at $32.3 million, down 36.44% from the prior year.
- Assets Average was $27.8 million for Q2 2026 at NextPlat, up from $27.2 million in the prior quarter.
- Over five years, Assets Average peaked at $65.3 million in Q4 2023 and troughed at $22.8 million in Q3 2022.
- A 5-year average of $36.6 million and a median of $29.9 million in 2023 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 759.8% in 2022 and plunged 44.2% in 2025, its largest moves.
- Over 5 years, Assets Average stood at $24.6 million in 2022, then soared by 165.69% to $65.3 million in 2023, then sank by 40.17% to $39.1 million in 2024, then decreased by 26.48% to $28.7 million in 2025, then retreated by 3.28% to $27.8 million in 2026.
- The last three Assets Average figures came in at $27.8 million (Q2 2026), $27.2 million (Q1 2026), and $28.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 24.65 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 1.46 Bn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.50 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 73.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 27.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.80 Mn |
| Mar 31, 2026 | 27.19 Mn |
| Dec 31, 2025 | 28.74 Mn |
| Sep 30, 2025 | 30.52 Mn |
| Jun 30, 2025 | 33.12 Mn |
| Mar 31, 2025 | 36.14 Mn |
| Dec 31, 2024 | 39.09 Mn |
| Sep 30, 2024 | 46.28 Mn |
| Jun 30, 2024 | 58.26 Mn |
| Mar 31, 2024 | 64.77 Mn |
| Dec 31, 2023 | 65.33 Mn |
| Sep 30, 2023 | 48.55 Mn |
| Jun 30, 2023 | 29.31 Mn |
| Mar 31, 2023 | 28.18 Mn |
| Dec 31, 2022 | 24.59 Mn |
| Sep 30, 2022 | 22.81 Mn |
| Jun 30, 2022 | 25.36 Mn |
| Mar 31, 2022 | 23.10 Mn |
| Dec 31, 2021 | 20.36 Mn |
| Sep 30, 2021 | 18.80 Mn |